3[6]Detry O, Arkadopoulos N, Ting P, et al. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg, 1999,65(10):934 被引量：1
4[7]Chen S C, Mullon C, Kahaku E, et al. Treatment of severe liver failure with a bioartificial liver. Ann N Y Acad Sci, 1997,831:350 被引量：1
5[8]Ellis A J, Hughes R D, Nicholl D, et al. Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the Biologic-DT. Int J Artif Organs, 1999,22(1):27 被引量：1
6[9]Watanbe F D, Mullon C J, Hewitt W R , et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg, 1997,225(5):484 被引量：1
7[10]Te Velde A A, Flendrig L M, Ladiges N C, et al. Immunological consequences of the use of xenogeneic hepatocytes in a bioartificial liver for acute liver failure. Int J Artif Organs, 1997,20(4):229 被引量：1
8[11]Baquerizo A, Mhoyan A, Kearns-Jonker M, et al. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation, 1999, 67(1):5 被引量：1
9[1]Rozga J, Demetriou A A. Artificial liver. Evolution and future perspectives. ASAIO J, 1995,41(4):831 被引量：1
10[2]Jauregui H O. Cellular component of bioartificial liver support systems. Artif Organs, 1999,23(10):889 被引量：1
3Sun Q F,Ding J G,Xu D Z,et al.Prediction of the prog- nosis of patients with acute failure using the model for on -chronic hepatitis B liver end-stage liver disease sco- ring system and a novel logistic regression model[J].J Viral Hepat, 2009,16(7) :464-470. 被引量：1
4Mckenzie T J, Lillegard J B, Nyberg S L. Artificial and bioaritifieial liver support [J]. Semin Liver Dis, 2008 (28) :210-217. 被引量：1
5Lee K,Mun C H,Min B G.Development of a multifunc- tional detoxifying unit for liver failure patients[J].Blood Purif, 2012,34 (3/4) : 225-230. 被引量：1
